State Street’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $89.2M | Buy |
|
|||||
|
2025
Q2 | $56.6M | Sell |
|
|||||
|
2025
Q1 | $69.2M | Buy |
|
|||||
|
2024
Q4 | $85M | Sell |
|
|||||
|
2024
Q3 | $84.8M | Buy |
|
|||||
|
2024
Q2 | $65.6M | Sell |
|
|||||
|
2024
Q1 | $103M | Sell |
|
|||||
|
2023
Q4 | $120M | Buy |
|
|||||
|
2023
Q3 | $89.9M | Buy |
|
|||||
|
2023
Q2 | $42.6M | Sell |
|
|||||
|
2023
Q1 | $42.5M | Sell |
|
|||||
|
2022
Q4 | $60.7M | Buy |
|
|||||
|
2022
Q3 | $48.5M | Buy |
|
|||||
|
2022
Q2 | $17.3M | Buy |
|
|||||
|
2022
Q1 | $13.7M | Sell |
|
|||||
|
2021
Q4 | $79.8M | Buy |
|
|||||
|
2021
Q3 | $37.8M | Buy |
|
|||||
|
2021
Q2 | $13.8M | Buy |
|